Seattle Genetics And Millennium Announce Initiation Of Phase I Combination Clinical Trial Of Brentuximab Vedotin For Front-line Hodgkin Lymphoma

Blood No Comments »

Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients…

Related Reading:

Can Blood Samples Predict Arthritic Rheumatism?

Blood No Comments »

Levels of inflammatory proteins, so-called cytokines, are elevated in the blood even before the onset of arthritic rheumatism…

Related Reading:

Early Cancer Testing Method In Development

Blood No Comments »

A new testing method is being developed to detect cancer soon after the tumor has formed. It will identify characteristic substances in the blood which accompany a certain type of tumor. The first steps in the development have already been completed. The earlier the doctor finds the tumor, the better the patient’s chances of recovery…

Related Reading:

Detection Of Circulating Tumor Cells In Peripheral Blood Of Patients With Renal Cell Carcinoma Correlates With Prognosis

Blood No Comments »

UroToday.com – The investigation of disseminated tumor cells in the peripheral blood, so-called circulating tumor cells (CTCs), has come more in focus recently. Small amounts of peripheral blood (16ml/patient) can easily be collected, and immunomagnetic enrichment of tumor cells followed by immunohistochemical detection on just one slide allows a fast and specific identification of CTCs…

Related Reading:

Discovery Of Potential New Target For Drugs To Treat Iron Deficiency And Overload

Blood No Comments »

The discovery of a major player in the body’s regulation of iron levels should provide a new target for drugs that prevent common iron deficiency as well as rare, potentially deadly iron overload, researchers said…

Related Reading:

Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A Single Agent For The Treatment Of Waldenstrom’s Macroglobulinemia

Blood No Comments »

Keryx Biopharmaceuticals, Inc…

Related Reading:

How Blood Flow Force Protects Blood Vessels

Blood No Comments »

It is second nature for most of us that exercise protects against heart attack and stroke, but researchers have spent 30 years unraveling the biochemistry behind the idea…

Related Reading:

Hematologists Can Now Earn CME Credits Through The Journal Blood

Blood No Comments »

The American Society of Hematology (ASH) now offers physicians who diagnose and treat blood disorders a new resource for earning continuing medical education (CME) credits while staying abreast of the latest clinical strategies in the rapidly changing field of hematology…

Related Reading:

Possible New Drug Target For Iron Deficiency, Overload

Blood No Comments »

US researchers have discovered a protein that appears to play an important role in regulating blood levels of iron and suggest it could be a new target for drugs to treat iron deficiency, which is quite common, as well as the much rarer opposite condition, iron overload. Corresponding author Dr…

Related Reading:

Fat Tissue May Be A Source Of Valuable Blood Stem Cells, Study Says

Blood No Comments »

Bone marrow is a leading source of adult stem cells, which are increasingly used for research and therapeutic interventions, but extracting the cells is an arduous and often painful process…

Related Reading:

WP Theme & Icons by N.Design Studio
Entries RSS Comments RSS Log in